MedTrace Logo

Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis

NCT00973817 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2013-04-08

No results posted yet for this study

Summary

The purpose of this study is to investigate the safety and efficacy of the use of ELAD in patients with diagnosed Acute On Chronic Hepatitis, including Acute Alcoholic Hepatitis.

Conditions

  • Acute On Chronic Hepatitis

Interventions

BIOLOGICAL

ELAD plus standard of care treatment

Use of ELAD plus standard of care

OTHER

Standard of care

Standard of care in the treatment of AOCH will be administered

Sponsors & Collaborators

  • Vital Therapies, Inc.

    lead INDUSTRY

Principal Investigators

  • Robert Ashley, MS · Vital Therapies, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
67 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2011-04-30
Completion
2011-05-31

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00973817 on ClinicalTrials.gov